Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 3/20 | 0.59 |
| ▸ | NPY1R | P25929 | 2/20 | 0.59 |
| ▸ | NPY2R | P49146 | 2/20 | 0.59 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.55 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.52 |
| ▸ | MME | P08473 | 3/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 3/20 | 0.51 |
| ▸ | CPA1 | P15085 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.51 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.50 |
| ▸ | CHRNG | P07510 | 1/20 | 0.50 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.50 |
| ▸ | CHRND | Q07001 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | NPPA | P01160 | 1/20 | 0.50 |
| ▸ | ECE1 | P42892 | 1/20 | 0.50 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15011504 | 1.00 | NPY4R (0.59) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL1373292 | 1.00 | NPY4R (0.59) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL30179294 | 0.97 | NPY4R (0.63) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| Acetic Acid SCHEMBL28326516 | 0.96 | NPY4R (0.59) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| Acetic Acid SCHEMBL20489334 | 0.96 | NPY4R (0.59) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL30772332 | 0.96 | NPY4R (0.64) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL4655518 | 0.96 | NPY1R (0.58) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| Lysylphenylalanyltyrosine SCHEMBL14583994 | 0.94 | NPY1R (0.60) | NPY4RNPY1RNPY2RMMEMMP2 | |
| Lysylphenylalanyltyrosine SCHEMBL4283579 | 0.94 | NPY1R (0.60) | NPY4RNPY1RNPY2RMMEMMP2 | |
| SCHEMBL30179482 | 0.94 | NPY1R (0.60) | NPY4RNPY1RNPY2RMMEMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110418837-B | Culture medium comprising oligopeptides | 赢创运营有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3372671-B1 | CULTURE MEDIUM COMPRISING OLGOPEPTIDES | EVONIK OPERATIONS GMBH (DE) | 2021-11-03 | — | — | EP | disclosed |
| CN-110418837-A | Culture medium comprising oligopeptides | EVONIK TECHNOCHEMIE GMBH | 2019-11-05 | — | — | CN | disclosed |
| WO-2018162346-A1 | CULTURE MEDIUM COMPRISING OLIGOPEPTIDES | EVONIK TECHNOCHEMIE GMBH (DE) | 2018-09-13 | — | — | WO | disclosed |
| EP-3372671-A1 | CULTURE MEDIUM COMPRISING OLGOPEPTIDES | Evonik Technochemie GmbH (DE) | 2018-09-12 | — | — | EP | disclosed |
| US-20160263235-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC (CA) | 2016-09-15 | — | — | US | disclosed |
| EP-2794663-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | Angiochem Inc. (CA) | 2014-10-29 | — | — | EP | disclosed |
| US-20110288011-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2011-11-24 | — | — | US | disclosed |
| WO-2010063124-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2010-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160263235-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | VIP, SLC1A5, SLC47A1 | NPY4R 39/4885NPY1R 22/4885NPY2R 94/4885 |
| US-20110288011-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | VIP, SLC1A5, SLC47A1 | NPY4R 39/4885NPY1R 22/4885NPY2R 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.